Analysing treatment trends and costs for hip or knee OA in Japan Clinical study 03 October 2020 Pages: 3 - 3
Assessing cost-effective options of cardiac rehab in the Czech Republic Clinical study 03 October 2020 Pages: 4 - 4
Burden of catastrophic healthcare expenditure in sub-Saharan Africa Clinical study 03 October 2020 Pages: 5 - 5
Burden of type 2 diabetes complications substantial in Sweden Clinical study 03 October 2020 Pages: 6 - 6
Cognitive behavioural therapy at various delivery modes cost effective Clinical study 03 October 2020 Pages: 7 - 7
Dabigatran cost effective in AF but stroke and bleeding risk important Clinical study 03 October 2020 Pages: 10 - 10
Earlier thrombectomy for acute ischaemic stroke increases NMB Clinical study 03 October 2020 Pages: 11 - 11
Early-stage cost-effectiveness analysis of novel drug for T1DM prevention Clinical study 03 October 2020 Pages: 12 - 12
Expanded testing for COVID-19 could be cost effective in USA Clinical study 03 October 2020 Pages: 14 - 14
Genotype-guided ticagrelor cost effective for stroke prevention in Asians Clinical study 03 October 2020 Pages: 16 - 16
HCV therapy reduces work loss and costs due to lost productivity Clinical study 03 October 2020 Pages: 17 - 17
Low-dose CT screening for lung cancer cost effective in smokers Clinical study 03 October 2020 Pages: 18 - 18
MicroRNA-based screening cost effective in diagnosing gastric cancer Clinical study 03 October 2020 Pages: 19 - 19
Mifepristone plus misoprostol less costly than misoprostol alone Clinical study 03 October 2020 Pages: 20 - 20
Mobile-based HIV counselling and testing cost effective in Ethiopia Clinical study 03 October 2020 Pages: 21 - 21
Narrow-band UVB plus corticosteroid cost effective for vitiligo Clinical study 03 October 2020 Pages: 23 - 23
Neonatal bloodstream infection substantial burden in Ghana Clinical study 03 October 2020 Pages: 24 - 24
Non-invasive test for diagnosis of invasive fungal infection saves cost Clinical study 03 October 2020 Pages: 25 - 25
Optimising treatment choices reduces burden of status epilepticus Clinical study 03 October 2020 Pages: 26 - 26
Spending on HCV medications much higher in the US than Canada Non-clinical study 03 October 2020 Pages: 28 - 28
State-wide price variation for generic BPH medications in Pennsylvania Non-clinical study 03 October 2020 Pages: 29 - 29
Tofacitinib cost saving in moderate-to-severe RA in China Clinical study 03 October 2020 Pages: 30 - 30
Use of biosimilars in patients with cancer in Germany would save costs Clinical study 03 October 2020 Pages: 31 - 31
Which oesophageal cancer screening strategy is cost effective in China? Clinical study 03 October 2020 Pages: 32 - 32
Zoledronic acid for secondary prevention of hip fractures cost effective Meeting report 03 October 2020 Pages: 33 - 33
NICE recommends osimertinib for advanced EGFR-positive NSCLC News item 03 October 2020 Pages: 35 - 35
Targeted immune modulators not cost effective in ulcerative colitis Review 03 October 2020 Pages: 36 - 36